Have you or your loved ones been diagnosed with bladder cancer?

You may be eligible to participate in a bladder cancer clinical trial.

Have you or your loved ones been diagnosed with bladder cancer? You may be eligible to participate in a bladder cancer clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Bladder Cancer Clinical Trial
NCT02324582 | Phase 1 | Interventional

Have you or your loved ones been diagnosed with bladder cancer?

You may be eligible to participate in a bladder cancer clinical trial.

Have you or your loved ones been diagnosed with bladder cancer? You may be eligible to participate in a bladder cancer clinical trial.

Active not recruiting

Male & Female

18 Years +

This study has recruited 13 Participants

This is a single center Phase I safety and efficacy study of MK-3475 therapy used in combination with bladder infused BCG treatment for patients, 18 years or older, with high risk superficial bladder cancer (cancer not yet involving the muscle of the bladder wall) who have had removal of their bladder tumor. Patients will be enrolled to a single treatment group of a fixed dose of MK 3475 and BCG.